Cargando…
A Prospective Observational Study of Hypogammaglobulinemia in the First Year After Lung Transplantation
BACKGROUND: Immunosuppressive therapies have led to improved survival for lung transplant (LT) recipients but these therapies can lead to hypogammaglobulinemia (HGG) and potentially an increased risk of infection. Large prospective studies have not been performed to evaluate the impact of HGG on out...
Autores principales: | Petrov, Andrej A., Traister, Russell S., Crespo, Maria M., Silveira, Fernanda P., Xie, Maylene, Coffey, Kara, Ensor, Christopher R., Landsittel, Douglass, Pilewski, Joseph M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092181/ https://www.ncbi.nlm.nih.gov/pubmed/30255132 http://dx.doi.org/10.1097/TXD.0000000000000811 |
Ejemplares similares
-
Cyclophosphamide for Refractory Acute Cellular Rejection After Lung Transplantation
por: Naik, Chetan, et al.
Publicado: (2018) -
The SHELTER Trial of Transplanting Hepatitis C Virus–Infected Lungs Into Uninfected Recipients
por: Reese, Peter P., et al.
Publicado: (2023) -
Viral Respiratory Tract Infection During the First Postoperative Year Is a Risk Factor for Chronic Rejection After Lung Transplantation
por: Magnusson, Jesper, et al.
Publicado: (2018) -
Lung Transplantation in Systemic Sclerosis: a Practice Survey of United States Lung Transplant Centers
por: Sehgal, Sameep, et al.
Publicado: (2021) -
Activin Biology After Lung Transplantation
por: Westall, Glen P., et al.
Publicado: (2017)